Detalles de la búsqueda
1.
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
Gastric Cancer
; 23(4): 689-698, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128634
2.
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(11): 1437-1448, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355453
3.
Assessment of safety and tolerability of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: Results of an open-label, randomized, multicenter, phase IIIB ESCAPE trial.
Cancer Treat Res Commun
; 40: 100817, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735220
4.
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study.
Blood Adv
; 5(17): 3354-3361, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477816
5.
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.
JAMA Oncol
; 6(1): e193531, 2020 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31600365
6.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial.
Lancet Haematol
; 4(8): e362-e373, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28712940
Resultados
1 -
6
de 6
1
Próxima >
>>